Orion Pharma Limited (DSE:ORIONPHARM)

Market Cap	7.00B -2.9%
Revenue (ttm)	3.12B -57.8%
Net Income	-569.37M
EPS	-2.43
Shares Out	234.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	282,274
Average Volume	324,979
Open	29.30
Previous Close	n/a
Day's Range	28.90 - 30.20
52-Week Range	22.90 - 42.90
Beta	-0.67
RSI	49.59
Earnings Date	Apr 29, 2026

About Orion Pharma

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. It produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. The company also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 2,954
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM